Sterling Biotech bank fraud case : ED attaches Rs 20 crore assets
New Delhi: More than ₹ 20 crore worth of assets have been attached under the anti-money laundering law in the alleged bank fraud case against Gujarat-based pharmaceutical group Sterling Biotech, the Enforcement Directorate (ED) said on Tuesday.
A provisional order has been issued by the Enforcement Directorate under the Prevention of Money Laundering Act (PMLA) to attach five immovable properties and an equal number of bank accounts of a company named Shimnit Utsch India Private Limited and its directors.
The total value of these assets is stated to be ₹ 20.77 crore.
Vadodara-based Sterling Biotech group is owned by brothers Nitin Sandesara and Chetan Sandesara.
The brothers, Dipti Sandesara (wife of Chetan Sandesara) and Hitesh Patel (a family member of the Sandesaras) have been declared fugitives under the Fugitive Economic Offenders Act by a special PMLA court in Mumbai.
They are stated to be based abroad and India is trying to extradite them.
Probe found, the ED said in a statement, that the Sandesaras had "diverted proceeds of crime of ₹ 55.13 crore to the accounts of Shimnit Utsch India Private Limited in the garb of share application money." "Out of the said diversion, an amount of ₹ 23.50 crore was still lying with Shimnit group and its promoters/directors," it said.
The agency has earlier attached properties worth ₹ 14,523 crore by issuing 14 such orders in this case.
With the latest order, the total attachment in this case stands at ₹ 14,543 crore, out of the proceeds of crime of more than ₹ 14,690.95 crore, it said.
Five charge sheets have been filed while four people have been arrested in the case till now.
The ED has alleged that the bank fraud involving the group is bigger than the Punjab National Bank (PNB) fraud allegedly perpetrated by fugitive diamantaires Nirav Modi and Mehul Choksi.
The Sterling Biotech case involves alleged fraud to the tune of about ₹ 16,000 crore. A consortium of banks led by Andhra Bank were alleged to have been duped.
The amount involved in the PNB case is pegged at about ₹ 13,400 crore.
The ED had registered a criminal case in connection with the alleged bank-loan fraud in 2017 on the basis of a CBI FIR.
Read also: Five firms including Cadila, Aurobindo Pharma in race to buy bankrupt Sterling Biotech
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.